SCOTUS takes up of gene patenting

Apr 22, 2013

The case focuses on the genes BRCA1 and BRCA2. These genes are used in tests to determine if a person has a heightened risk of hereditary ovarian or breast cancer.
Credit via Wikimedia Commons

  The Supreme Court heard arguments last week about whether human genes can be patented. The court’s ruling could drastically change the biotech industry and also the way universities do research.

Jennifer Carter-Johnson is an assistant law professor at Michigan State University. She’s an expert in intellectual property law, and she has a P.H.D. in microbiology. Carter-Johnson chats with Current State’s Emanuele Berry about the potential impacts of the Supreme Court's latest case.